Free Trial

Xometry, Inc. (NASDAQ:XMTR) Shares Sold by Tower Research Capital LLC TRC

Xometry logo with Industrials background

Tower Research Capital LLC TRC lessened its stake in shares of Xometry, Inc. (NASDAQ:XMTR - Free Report) by 93.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 625 shares of the company's stock after selling 8,805 shares during the period. Tower Research Capital LLC TRC's holdings in Xometry were worth $27,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Global Retirement Partners LLC purchased a new stake in Xometry in the fourth quarter valued at approximately $27,000. Canada Pension Plan Investment Board purchased a new position in shares of Xometry during the 4th quarter valued at approximately $38,000. SBI Securities Co. Ltd. purchased a new position in Xometry in the 4th quarter valued at about $73,000. Summit Investment Advisors Inc. lifted its position in shares of Xometry by 8.1% in the fourth quarter. Summit Investment Advisors Inc. now owns 4,447 shares of the company's stock valued at $190,000 after acquiring an additional 333 shares in the last quarter. Finally, Victory Capital Management Inc. acquired a new position in Xometry during the fourth quarter worth about $219,000. Institutional investors and hedge funds own 97.31% of the company's stock.

Xometry Trading Up 2.4%

Shares of NASDAQ:XMTR traded up $0.83 during mid-day trading on Tuesday, reaching $34.93. 641,541 shares of the company were exchanged, compared to its average volume of 597,362. Xometry, Inc. has a 1 year low of $11.08 and a 1 year high of $45.33. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.59 and a quick ratio of 4.55. The firm's 50-day simple moving average is $25.60 and its 200 day simple moving average is $30.80. The firm has a market cap of $1.76 billion, a price-to-earnings ratio of -33.27 and a beta of 0.71.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on XMTR. The Goldman Sachs Group boosted their target price on Xometry from $30.00 to $33.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. Citigroup dropped their target price on Xometry from $46.00 to $39.00 and set a "buy" rating for the company in a report on Thursday, February 27th. JMP Securities reiterated a "market outperform" rating and set a $42.00 price target on shares of Xometry in a report on Monday, February 10th. UBS Group upped their price objective on shares of Xometry from $33.00 to $35.00 and gave the company a "neutral" rating in a report on Wednesday, May 7th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Xometry from $45.00 to $30.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. One analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $34.89.

Check Out Our Latest Stock Analysis on XMTR

Insiders Place Their Bets

In other news, Director Emily Rollins sold 10,041 shares of the business's stock in a transaction dated Friday, May 9th. The stock was sold at an average price of $30.70, for a total transaction of $308,258.70. Following the completion of the transaction, the director now directly owns 11,105 shares of the company's stock, valued at approximately $340,923.50. The trade was a 47.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO James Miln sold 7,235 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $26.61, for a total transaction of $192,523.35. Following the completion of the sale, the chief financial officer now directly owns 131,090 shares in the company, valued at approximately $3,488,304.90. This trade represents a 5.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 85,297 shares of company stock worth $2,214,438 over the last ninety days. Corporate insiders own 9.66% of the company's stock.

About Xometry

(Free Report)

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

Further Reading

Institutional Ownership by Quarter for Xometry (NASDAQ:XMTR)

Should You Invest $1,000 in Xometry Right Now?

Before you consider Xometry, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.

While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines